BAYERCROP — Bayer Cropscience Balance Sheet
0.000.00%
- IN₹244.98bn
- IN₹236.74bn
- IN₹54.73bn
- 73
- 15
- 33
- 33
Annual balance sheet for Bayer Cropscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12,567 | 8,194 | 9,019 | 12,107 | 9,286 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,932 | 11,240 | 10,841 | 10,551 | 9,521 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 35,439 | 35,755 | 38,964 | 39,055 | 44,716 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,008 | 4,504 | 4,313 | 3,826 | 4,274 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 42,393 | 43,529 | 46,786 | 45,971 | 52,459 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,706 | 16,593 | 17,775 | 15,974 | 22,237 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,890 | 18,286 | 19,665 | 17,477 | 23,955 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 25,503 | 25,243 | 27,121 | 28,494 | 28,504 |
Total Liabilities & Shareholders' Equity | 42,393 | 43,529 | 46,786 | 45,971 | 52,459 |
Total Common Shares Outstanding |